1. Home
  2. MBI vs ESPR Comparison

MBI vs ESPR Comparison

Compare MBI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MBIA Inc.

MBI

MBIA Inc.

HOLD

Current Price

$7.10

Market Cap

381.2M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.95

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBI
ESPR
Founded
1973
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
381.2M
898.5M
IPO Year
1987
2013

Fundamental Metrics

Financial Performance
Metric
MBI
ESPR
Price
$7.10
$3.95
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
$8.50
$6.67
AVG Volume (30 Days)
334.9K
6.5M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$93,000,000.00
$303,802,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
285.71
2.83
52 Week Low
$3.86
$0.69
52 Week High
$8.26
$4.13

Technical Indicators

Market Signals
Indicator
MBI
ESPR
Relative Strength Index (RSI) 42.26 59.47
Support Level $6.93 $3.63
Resistance Level $7.85 $4.13
Average True Range (ATR) 0.27 0.20
MACD -0.06 -0.02
Stochastic Oscillator 18.48 64.00

Price Performance

Historical Comparison
MBI
ESPR

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: